CTOs on the Move

Edmund Optics

www.edmundoptics.com

 
Edmund Optics (EO) has been a leading supplier of precision optics and optical components since 1942, designing and manufacturing a wide array of multi-element optical lenses, lens coatings, imaging systems, and optomechanical equipment. Led by a staff of skilled optical engineers and scientists, EO is application focused and pursues new ways to implement optical technology, enabling advancements in industrial metrology, semiconductor manufacturing, life sciences, and more. EO is a worldwide presence in industrial optics extending well beyond our original manufacturing plant and corporate headquarters in Barrington, New Jersey, USA.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Melanie Matheu
CTO Profile
Ekaterina Golovchenko
Senior Vice President of Technology and Development Profile

Similar Companies

Cyclehaus

Our 50-minute Indoor Cycling class is a complete immersion into a high-intensity environment of energy and exercise. Our workouts are perfectly tailored to cutting edge playlists, and designed to be a retreat from everyday life. Each ride, physically and mentally stimulating, will challenge you to new heights.

E*Health Line.com

E*Health Line.com, Inc. is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hospice Of Marion County

Hospice Of Marion County is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Hospice Of Marion County is based in Ocala, FL. You can find more information on Hospice Of Marion County at www.hospiceofmarion.com

BlackSea Technologies

BlackSea Technologies is a naval technology firm that enables new asymmetric strategies so U.S. Naval and military forces can prevail over the next several decades in multi-dimensional conflicts.

MSI

MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).